Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECT/CT for the Characterization of Renal Masses: Impact on Clinical Decision Making

NCT03996850 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT03996850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECT/CT for the Characterization of Renal Masses: Impact on Clinical Decision Making
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
December 7, 2018
Completion date
December 31, 2027
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney neoplasm, renal mass